YZY Bio

company

About

YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies.

  • Wuhan,Hubei,China
  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
¥250M
Industries
Biotechnology,Health Care,Pharmaceutical,Product Research
Founded date
Jul 1, 2010
Number Of Employee
51 - 100
Operating Status
Active
Legal Name
Wuhan YZY Biopharma Co., Ltd.
Also Known As
友芝友生物制药,Youzhiyou Biopharmaceuticals

YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies based on breakthrough discoveries in molecular biology, enabling patients with major diseases to obtain more efficient treatment solutions.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥450M
YZY Bio has raised a total of ¥450M in funding over 2 rounds. Their latest funding was raised on Jul 4, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 4, 2022 Series C ¥200M Detail
Sep 13, 2021 Series B ¥250M 4 Detail

Investors

Number of Lead Investors
Number of Investors
4
YZY Bio is funded by 4 investors. TD Capital and Sanhua Hongdao Investment are the most recent investors.
Investor Name Lead Investor Funding Round
TD Capital Series B
Sanhua Hongdao Investment Series B
Wuhan Institute of Biotechnology Series B
BGI Co-Win Series B

Employee Profiles

Number of Employee Profiles
1
YZY Bio has 1 current employee profiles, including Executive Pengfei Zhou
Executive